POP-OUT | CLOSE
 
 
4-{[4-({4-[(E)-2-cyanoethenyl]-2,6-dimethylphenyl}amino)pyrimidin-2-yl]amino}benzonitrile
 
T27 is found in 14 entries
T27
  •   Chemical Component Summary   Hide
    Name 4-{[4-({4-[(E)-2-cyanoethenyl]-2,6-dimethylphenyl}amino)pyrimidin-2-yl]amino}benzonitrile
    Identifiers 4-[[4-[[4-[(E)-2-cyanoethenyl]-2,6-dimethyl-phenyl]amino]pyrimidin-2-yl]amino]benzenecarbonitrile
    Synonyms Rilipivirine
    Formula C22 H18 N6
    Molecular Weight 366.42 g/mol
    Type non-polymer
    Isomeric SMILES
    InChI
    InChI key YIBOMRUWOWDFLG-ONEGZZNKSA-N
     
  •   Drug Info: DrugBank Hide
    DrugBank ID DB08864   (Different stereochemistry)
    Name Rilpivirine
    Groups approved
    Description Rilpivirine is non-nucleoside reverse transcriptase inhibitor (NNRTI) which is used for the treatment of HIV-1 infections in treatment-naive patients. It is a diarylpyrimidine, a class of molecules that resemble pyrimidine nucleotides found in DNA. Because of its flexible chemical structure, resistance of rilpivirine is less likely to develop than other NNRTI's. FDA approved on May 20, 2011.
    Synonyms TMC278
    Salts Rilpivirine Hydrochlorie
    Brand names Edurant
    Affected organism Human Immunodeficiency Virus
    Indication Treatment of HIV-1 infections in treatment-naive patients with HIV-1 RNA ≤100,000 copies/mL in combination with at least 2 other antiretroviral agents.
    Pharmacology Rilpivirine is the most potent NNRTI and has a EC50 of 0.73 nM in vitro against HIV-1 because its chemical structure allowed for better binding to reverse transcriptase.
    Mechanism of action Rilpivirine is an NNRTI which binds to reverse transcriptase which results in a block in RNA and DNA- dependent DNA polymerase activities. One such activity is HIV-1 replication. Intracellular phosphorylation is not necessary for its antiviral activity. Because of the structure of rilpivirine is flexible around the aromatic rings, the molecule can have multiple conformations so that can bind to residues in the reverse transcriptase enzyme which have a lower mutation rate.
    Route of administration Oral
    Categories Antiviral Agents
    ATC-Code J05AG05
    AHFS-Code 8:18.08.16
    CAS number 500287-72-9
    Targets
    Name Sequence search Pharmacological action Actions
    Nuclear receptor subfamily 1 group I member 2   Search  unknown agonist
     
Ligand Image